134 related articles for article (PubMed ID: 8393867)
1. Regulation-defective mutants of type I cAMP-dependent protein kinase. Consequences of replacing arginine 94 and arginine 95.
Buechler YJ; Herberg FW; Taylor SS
J Biol Chem; 1993 Aug; 268(22):16495-503. PubMed ID: 8393867
[TBL] [Abstract][Full Text] [Related]
2. Role of MgATP in the activation and reassociation of cAMP-dependent protein kinase I: consequences of replacing the essential arginine in cAMP binding site A.
Neitzel JJ; Dostmann WR; Taylor SS
Biochemistry; 1991 Jan; 30(3):733-9. PubMed ID: 1846304
[TBL] [Abstract][Full Text] [Related]
3. Identification of critical determinants for autoinhibition in the pseudosubstrate region of type I alpha cAMP-dependent protein kinase.
Poteet-Smith CE; Shabb JB; Francis SH; Corbin JD
J Biol Chem; 1997 Jan; 272(1):379-88. PubMed ID: 8995272
[TBL] [Abstract][Full Text] [Related]
4. Mutations in the autoinhibitor site of the regulatory subunit of cAMP-dependent protein kinase I. Replacement of Ala-97 and Ser-99 interferes with reassociation with the catalytic subunit.
Buechler YJ; Taylor SS
J Biol Chem; 1991 Feb; 266(6):3491-7. PubMed ID: 1847375
[TBL] [Abstract][Full Text] [Related]
5. Dissecting the domain structure of the regulatory subunit of cAMP-dependent protein kinase I and elucidating the role of MgATP.
Ringheim GE; Taylor SS
J Biol Chem; 1990 Mar; 265(9):4800-8. PubMed ID: 2156855
[TBL] [Abstract][Full Text] [Related]
6. Holoenzyme interaction sites in the cAMP-dependent protein kinase. Histidine 87 in the catalytic subunit complements serine 99 in the type I regulatory subunit.
Cox S; Taylor SS
J Biol Chem; 1994 Sep; 269(36):22614-22. PubMed ID: 8077212
[TBL] [Abstract][Full Text] [Related]
7. A point mutation abolishes binding of cAMP to site A in the regulatory subunit of cAMP-dependent protein kinase.
Bubis J; Neitzel JJ; Saraswat LD; Taylor SS
J Biol Chem; 1988 Jul; 263(20):9668-73. PubMed ID: 2898473
[TBL] [Abstract][Full Text] [Related]
8. A constitutively active holoenzyme form of the cAMP-dependent protein kinase.
Wang YH; Scott JD; McKnight GS; Krebs EG
Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2446-50. PubMed ID: 1848703
[TBL] [Abstract][Full Text] [Related]
9. Active site mutations define the pathway for the cooperative activation of cAMP-dependent protein kinase.
Herberg FW; Taylor SS; Dostmann WR
Biochemistry; 1996 Mar; 35(9):2934-42. PubMed ID: 8608131
[TBL] [Abstract][Full Text] [Related]
10. High affinity binding of the heat-stable protein kinase inhibitor to the catalytic subunit of cAMP-dependent protein kinase is selectively abolished by mutation of Arg133.
Wen W; Taylor SS
J Biol Chem; 1994 Mar; 269(11):8423-30. PubMed ID: 8132568
[TBL] [Abstract][Full Text] [Related]
11. The consequences of introducing an autophosphorylation site into the type I regulatory subunit of cAMP-dependent protein kinase.
Durgerian S; Taylor SS
J Biol Chem; 1989 Jun; 264(17):9807-13. PubMed ID: 2656713
[TBL] [Abstract][Full Text] [Related]
12. Functional characterization of cAMP-binding mutations in type I protein kinase.
Correll LA; Woodford TA; Corbin JD; Mellon PL; McKnight GS
J Biol Chem; 1989 Oct; 264(28):16672-8. PubMed ID: 2550452
[TBL] [Abstract][Full Text] [Related]
13. cAMP-dependent protein kinase regulatory subunit type IIbeta: active site mutations define an isoform-specific network for allosteric signaling by cAMP.
Zawadzki KM; Taylor SS
J Biol Chem; 2004 Feb; 279(8):7029-36. PubMed ID: 14625280
[TBL] [Abstract][Full Text] [Related]
14. Expression and characterization of mutant forms of the type I regulatory subunit of cAMP-dependent protein kinase. The effect of defective cAMP binding on holoenzyme activation.
Woodford TA; Correll LA; McKnight GS; Corbin JD
J Biol Chem; 1989 Aug; 264(22):13321-8. PubMed ID: 2546952
[TBL] [Abstract][Full Text] [Related]
15. Identifying the molecular switches that determine whether (Rp)-cAMPS functions as an antagonist or an agonist in the activation of cAMP-dependent protein kinase I.
Dostmann WR; Taylor SS
Biochemistry; 1991 Sep; 30(35):8710-6. PubMed ID: 1653606
[TBL] [Abstract][Full Text] [Related]
16. Systematic mutational analysis of cAMP-dependent protein kinase identifies unregulated catalytic subunits and defines regions important for the recognition of the regulatory subunit.
Gibbs CS; Knighton DR; Sowadski JM; Taylor SS; Zoller MJ
J Biol Chem; 1992 Mar; 267(7):4806-14. PubMed ID: 1537860
[TBL] [Abstract][Full Text] [Related]
17. Arginine 210 is not a critical residue for the allosteric interactions mediated by binding of cyclic AMP to site A of regulatory (RIalpha) subunit of cyclic AMP-dependent protein kinase.
Steinberg RA; Symcox MM; Sollid S; Ogreid D
J Biol Chem; 1996 Nov; 271(44):27630-6. PubMed ID: 8910352
[TBL] [Abstract][Full Text] [Related]
18. Effects of cAMP-binding site mutations on intradomain cross-communication in the regulatory subunit of cAMP-dependent protein kinase I.
Ringheim GE; Taylor SS
J Biol Chem; 1990 Nov; 265(32):19472-8. PubMed ID: 2174038
[TBL] [Abstract][Full Text] [Related]
19. Holoenzymes of cAMP-dependent protein kinase containing the neural form of type I regulatory subunit have an increased sensitivity to cyclic nucleotides.
Cadd GG; Uhler MD; McKnight GS
J Biol Chem; 1990 Nov; 265(32):19502-6. PubMed ID: 2174040
[TBL] [Abstract][Full Text] [Related]
20. Crosstalk between domains in the regulatory subunit of cAMP-dependent protein kinase: influence of amino terminus on cAMP binding and holoenzyme formation.
Herberg FW; Dostmann WR; Zorn M; Davis SJ; Taylor SS
Biochemistry; 1994 Jun; 33(23):7485-94. PubMed ID: 8003514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
